MetaCap

Azora Therapeutics (AZR) vs Tenax Therapeutics (TENX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Tenax Therapeutics is the larger company by market cap ($56.9 million vs $55.0 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

AZR-24.51%TENX-33.51%
+2%-17%-35%
Oct 28, 20261 yearNov 20, 2026
AZR+1.05%TENX-30.17%
+9%-11%-32%
Oct 26, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

AZR versus TENX key metrics
MetricAZRTENX
Share price$3.85$1.25
Market cap$55.00M$56.92M
1-day change-0.52%-10.07%
YTD return—-89.75%
1-year return—-84.66%
5-year return—-99.94%
EPS (TTM)$-18.09$-1.39
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$0
Net income (latest FY)$-7.98M$-52.60M
52-week high$8.25$19.40
52-week low$1.31$1.24
Distance from 52-week high-53.33%-93.56%
Analyst consensus—none
Avg. price target upside—+904.80%
Average volume50.12K3.15M
Shares outstanding14.29M45.54M
Employees—14
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Tenax Therapeutics

TENX stock →

Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia.

Health Care · Biotechnology: Pharmaceutical Preparations · 14 employees

AZR vs TENX FAQ

Which is bigger, Azora Therapeutics or Tenax Therapeutics?

Tenax Therapeutics (TENX) is larger, with a market capitalization of $56.92M compared with $55.00M for Azora Therapeutics (AZR).

Are Azora Therapeutics and Tenax Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons